HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Foslevodopa

HCID 127766
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
101141-95-1
Standard SMILES
N[C@@H](Cc1ccc(OP(=O)(O)O)c(O)c1)C(=O)O
InChIKey
YNDMEEULGSTYJT-LURJTMIESA-N
Molecular formula
C9H12NO7P
Average molar mass
277.17 g/mol
Monoisotopic mass
277.03513835

Overview

Foslevodopa is an L-tyrosine derivative that is L-dopa in which the hydroxy group at position 4' is replaced by a phosphonooxy group. It is a water-soluble prodrug of levodopa which is used for the treatment of Parkinson's disease. It has a role as an antiparkinson drug and a prodrug. It is an O-phosphoamino acid, a L-tyrosine derivative and a non-proteinogenic L-alpha-amino acid. It is functionally related to a L-dopa.

Names & identifiers

Preferred name
Foslevodopa
IUPAC
(2S)-2-amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic acid
English name
DOPA 4-phosphate
Molecular formula
C9H12NO7P
Molecular weight
277.167841

Names & synonyms

Foslevodopa97321-87-4Levodopa-4'-monophosphate3-hydroxy-O-phosphono-L-tyrosineFoslevodopa [USAN](2S)-2-amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic acid37NQZ0J76IFOSLEVODOPA [INN]FOSLEVODOPA [JAN]ABBV-951 COMPONENT FOSLEVODOPAL-TYROSINE, 3-HYDROXY-O-PHOSPHONO-L-TYROSINE, 3-HYDROXY-, 4-(DIHYDROGEN PHOSPHATE)
Show more names
DOPA 4-PHOSPHONATE
foslevodopumRefChem:600352Dopa 4-phosphateABBV-951101141-95-1UNII-37NQZ0J76IWHO 11006(S)-2-amino-3-(3-hydroxy-4-(phosphonooxy)phenyl)propanoic acid

Database identifiers

CAS
101141-95-1、97321-87-4
PubChem CID
127766
DTXSID
DTXSID70905957
ChEMBL
CHEMBL4594379
ChEBI
CHEBI:192509
UNII
37NQZ0J76I
Nikkaji
J3.795.603A

Properties

Computed structural properties

XLogP
-4
Topological polar surface area
150 Ų
Hydrogen bond donors
5
Hydrogen bond acceptors
8
Rotatable bonds
5
Heavy atoms
18
Formal charge
0
Complexity
344

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Chemistry & industry

Suppliers12 total

上海沛灵生物科技有限公司13127581762 13127581762 · [email protected]
Hefei TianRui Pharmaceutical Chemical Co., Ltd.+86-0551-68665055 +86-+86-18616906106 · [email protected]
合肥天瑞药物化学有限公司0551-68933033 13956024211
Chongqing jooe co., ltd+86-15223382610 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
成都同创源医药科技有限公司028-83379370 13880556291 · [email protected]
上海康满林生物医药有限公司68080707 15021879576 · [email protected]
济南尚博医药股份有限公司0531-61320525 15866703830 · [email protected]
上海智乾生物科技有限公司[email protected]
济南尚博生物科技有限公司+8615866703830 · [email protected]
TargetMol中国(陶术生物)15002134094 · [email protected]
南京沃格尼化工有限公司15996452985 · [email protected]
Additional notes · 1 item

DefinitionChEBI: Foslevodopa is an L-tyrosine derivative that is L-dopa in which the hydroxy group at position 4' is replaced by a phosphonooxy group. It is a water-soluble prodrug of levodopa which is used for the treatment of Parkinson's disease. It has a role as an antiparkinson drug and a prodrug. It is a L-tyrosine derivative, a non-proteinogenic L-alpha-amino acid and an O-phosphoamino acid. It is functionally related to a L-dopa.

Related reactions

1 records
New reaction record
HRID 62228 reaction equation
HRID 62228As productuspto-grants-2016_09

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes